Electrophysiologic effects of salbutamol, a beta2-selective agonist.
about
The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary diseaseComparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysisRegulation of gap-junction protein connexin 43 by beta-adrenergic receptor stimulation in rat cardiomyocytesAtrial flutter versus atrial fibrillation in a general population: differences in comorbidities associated with their respective onset.β2-adrenergic stress evaluation of coronary endothelial-dependent vasodilator function in mice using (11)C-acetate micro-PET imaging of myocardial blood flow and oxidative metabolism.Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease.
P2860
Electrophysiologic effects of salbutamol, a beta2-selective agonist.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Electrophysiologic effects of salbutamol, a beta2-selective agonist.
@en
Electrophysiologic effects of salbutamol, a beta2-selective agonist.
@nl
type
label
Electrophysiologic effects of salbutamol, a beta2-selective agonist.
@en
Electrophysiologic effects of salbutamol, a beta2-selective agonist.
@nl
prefLabel
Electrophysiologic effects of salbutamol, a beta2-selective agonist.
@en
Electrophysiologic effects of salbutamol, a beta2-selective agonist.
@nl
P2093
P2860
P1476
Electrophysiologic effects of salbutamol, a beta2-selective agonist.
@en
P2093
Anders Juhlin-Dannfelt
Hans Vallin
Per Insulander
Ulla Freyschuss
P2860
P304
P356
10.1046/J.1540-8167.2004.03105.X
P577
2004-03-01T00:00:00Z